6V7F
Human Arginase1 Complexed with Bicyclic Inhibitor Compound 13
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | APS BEAMLINE 17-ID |
Synchrotron site | APS |
Beamline | 17-ID |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2017-12-15 |
Detector | DECTRIS PILATUS 6M |
Wavelength(s) | 1.0000 |
Spacegroup name | P 1 21 1 |
Unit cell lengths | 53.510, 285.560, 67.160 |
Unit cell angles | 90.00, 90.04, 90.00 |
Refinement procedure
Resolution | 47.590 - 2.020 |
R-factor | 0.231 |
Rwork | 0.230 |
R-free | 0.25800 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 6v7c |
RMSD bond length | 0.009 |
RMSD bond angle | 1.110 |
Data reduction software | XDS |
Data scaling software | autoPROC |
Phasing software | autoBUSTER |
Refinement software | BUSTER (2.11.7) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 47.590 | 2.060 |
High resolution limit [Å] | 2.020 | 2.020 |
Rmerge | 0.170 | 0.490 |
Number of reflections | 121309 | 5351 |
<I/σ(I)> | 5.1 | 2.1 |
Completeness [%] | 93.0 | |
Redundancy | 3.1 | |
CC(1/2) | 0.970 | 0.730 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION | 7 | 293 | 10% MMT (pH 7.0) 0.1 M ammonium formate, 16-22% PEG 8000 |